CANY
ESRX

Caxton Associates (New York)’s Express Scripts Holding Company ESRX Stock Holding History

Caxton Associates (New York)’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,300
Closed -$209K – 590
2017
Q3 		$209K Buy
+3,300
New +$205K 0.01% 469
2017
Q2 		– Sell
-7,100
Closed -$468K – 607
2017
Q1 		$468K Buy
+7,100
New +$489K ﹤0.01% 267

Other funds holding ESRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Caxton Associates (New York)'s ESRX Position: Q4 2017 in Review

Caxton Associates (New York) sold out of Express Scripts Holding Company (ESRX) in Q4 2017, closing a stake of 3,300 shares — an estimated $209K sold.

Caxton Associates (New York) first reported a position in ESRX in Q1 2017 and held it in 2 quarters. The position peaked at $468K in Q1 2017. 1,109 funds tracked by Wall St. Rank hold ESRX as of Q4 2017.

  • Caxton Associates (New York) reported no remaining Express Scripts Holding Company position as of Q4 2017 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,300 Express Scripts Holding Company shares in Q4 2017, an estimated $209K.
  • Caxton Associates (New York) first reported a position in Express Scripts Holding Company in Q1 2017 and held it in 2 quarters.
  • Caxton Associates (New York)'s Express Scripts Holding Company position peaked at $468K in Q1 2017.
  • 1,109 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2017.

Based on Caxton Associates (New York)'s 13F filing for Q4 2017, filed 14 Feb 2018.